Table TDI-37. Amphetamines and ecstasy clients entering drug treatment, 2009 or most recent year available [see all tables in this series...]

Part (i) All clients by country and primary drug and type of treatment unit

Country		Amphetamines		MDMA and other derivatives
		Outpatient	Inpatient	Outpatient	Inpatient
Belgium		701	134	72	11
Bulgaria		17	3	3	0
Czech Republic		821	1214	3	0
Denmark		367	28	18	0
Germany	(1)	:	:	:	:
Estonia	(2)	15	:	0	:
Ireland		27	2	44	14
Greece		1	1	1	1
Spain	(3)	424	:	164	:
France		65	1	120	2
Italy		44	:	86	:
Cyprus		2	:	2	:
Latvia		:	:	:	:
Lithuania	(1)	:	:	:	:
Luxembourg		0	1	0	1
Hungary		386	12	40	0
Malta	(4)	1	:	11	:
Netherlands	(5)	577	59	45	3
Austria		57	16	11	5
Poland	(6)	514	:	19	:
Portugal		:	:	:	:
Romania		0	3	2	2
Slovenia		4	:	1	:
Slovakia		226	214	2	0
Finland		178	150	1	1
Sweden		513	922	4	10
United Kingdom		4180	73	442	1
Croatia		135	2	49	5
Turkey		:	0	:	31
Norway		:	:	:	:

Notes:

 : Indicates data are not available.   

 (1) Only aggregated data for stimulants (other than cocaine) are available.           

 (2) Outpatient data refers to outpatient and inpatient treatment centres (aggregated data).           

 (3) Last data available refer to 2008 and to outpatient and prisons treatment centres (aggregated data).           

 (4) Data for Outpatient refers to outpatient and inpatient treatment centres, low-threshold services and prisons (aggregated data). 

 (5) Data for outpatient centres refer to outpatient centres, inpatient centres and low-threshold agencies (aggregated data). 

 (6) Data refers to 2008 and to 33 health care units.           

 The number of treatment clients in each country is listed in Table TDI-7. 

 See also 'General notes for interpreting data’ on the Explanatory notes and help page. 

Sources:

 Reitox national reports 2010 — TDI. See Table TDI-0 for details on sources. 

• Download this data in Excel (.xls) format

(see the help page for information about formats etc.)